BRUSSELS (Reuters) - A proposed waiver of intellectual property rights for COVID-19 vaccines and treatments is "no silver bullet", European Council president Charles Michel said on Thursday, adding he expected the topic to feature at the G7 summit.
"The question of intellectual property rights will likely be raised," Michel told a news conference ahead of the summit starting on Friday.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!